Bis-(2-chloroethyl) sulfide (sulfur mustard; SM) is a potent alkylating agent. Three treatment compounds have been shown to limit SM damage in the mouse ear vesicant model: dimercaprol, octyl homovanillamide, and indomethacin. Microarrays were used to determine gene expression profiles of biopsies taken from mouse ears after exposure to SM in the presence or absence of treatment compounds. Mouse ears were topically exposed to SM alone or were pretreated for 15 min with a treatment compound and then exposed to SM. Ear tissue was harvested 24 h after exposure for ear weight determination, the endpoint used to evaluate treatment compound efficacy. RNA extracted from the tissues was used to generate microarray probes for gene expression profiling of therapeutic responses. Principal component analysis of the gene expression data revealed partitioning of the samples based on treatment compound and SM exposure. Patterns of gene responses to the treatment compounds were indicative of exposure condition and were phenotypically anchored to ear weight. Pretreatment with indomethacin, the least effective treatment compound, produced ear weights close to those treated with SM alone. Ear weights from animals pretreated with dimercaprol or octyl homovanillamide were more closely associated with exposure to vehicle alone. Correlation coefficients between gene expression level and ear weight revealed genes involved in mediating responses to both SM exposure and treatment compounds. These data provide a basis for elucidating the mechanisms of response to SM and drug treatment and also provide a basis for developing strategies to accelerate development of effective SM medical countermeasures.
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Bis-(2-chloroethyl) sulfide (sulfur mustard; SM) is a potent bifunctional alkylating agent capable of modifying and crosslinking cellular macromolecules such as DNA and protein by nucleophilic attack (Papirmeister et al., 1991) . SM exposure can produce debilitating pulmonary, ocular, and cutaneous injuries. After cutaneous exposure to SM, there is a dosedependent latent phase of 8 to 24 h that precedes clinical expression of tissue damage. Erythema occurs initially and is followed by vesication because of separation at the epidermal-dermal junction. This results in large fluid-filled lesions that are long-lasting and slow to heal (Papirmeister et al., 1991; Petrali and Oglesby-Megee, 1997) . The formation of blisters is accompanied by a potent inflammatory response, observed as increased production of inflammatory mediators and infiltration of the exposure area by activated immune cells (Rikimaru et al., 1991; Tsuruta et al., 1996; Sabourin et al., 2000 Sabourin et al., , 2002 .
The mouse ear vesicant model was developed to rapidly screen for potential SM treatment compounds (Casillas et al., 1997) . In this animal model, ear weight was determined as a measure of edema and inflammation and was used as a rapid, cost-effective endpoint to determine compound efficacy. Three potential antivesicant treatment compounds were identified using this screening paradigm: 2,3-dimercapto-1-propanol (dimercaprol, British anti-Lewisite), 2-(4-hydroxy-3-methoxy-phenyl)-N-octyl-ethanamide (octyl homovanillamide; OHV), and 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-yl]acetic acid (indomethacin) . Dimercaprol has been used as a treatment for exposure to the chemical warfare agent Lewisite (another vesicant) and also for heavy metal poisoning. Octyl homovanillamide is a vanilloid receptor agonist, and indomethacin is a classic nonsteroidal anti-inflammatory compound.
The mechanism of toxicity of SM is not well characterized, and previous studies have used DNA microarray technology to gain greater insight into the molecular pathways perturbed by SM exposure (Rogers et al., 2004; Sabourin et al., 2004a) . Based on these studies, we hypothesized that gene expression profiling of mouse ear skin exposed to SM alone or pretreated with one of these treatment compounds would provide important insight into the mechanism of cutaneous toxicity of SM and might identify genes and biological pathways involved in the response to SM exposure.
Materials and Methods

SM Exposure and Drug Treatments.
Outbred male CD-1 mice (28 -33 g; Charles River Laboratories, Portage, MI) were anesthetized with a combination of ketamine (60 mg/kg) and xylazine (12 mg/kg) administered i.p. A single 5-l application of SM (0.08 mg; 0.5 mol) in methylene chloride was applied topically to the inner surface of the right ear. The left ear (vehicle control) was exposed to 5 l of methylene chloride only. For drug treatment, animals were administered 10 l of dimercaprol (6.25 mg; 50.3 mol), 30 l of OHV (0.585 mg; 1.995 mol), or 20 l of indomethacin (1.34 mg; 3.74 mol) in ethanol 15 min before SM challenge. Each drug compound was tested at the maximum tolerated dose. A group of animals received drug in ethanol on the right ear and an equal volume of ethanol (drug vehicle) on the left ear. A group of untreated, unexposed animals served as naive controls. At 24 h postexposure, animals were euthanized, and an 8-mm-diameter ear punch biopsy was obtained. The ear punch biopsy was weighed and immediately frozen in liquid nitrogen. In conducting the research described in this report, the investigators adhered to the Guide for the Care and Use of Laboratory Animals by the Institute of Laboratory Animal Resources, National Research Council, in accordance with the stipulations mandated for an Association for Assessment and Accreditation of Laboratory Animal Care International-accredited facility.
Microarray Procedures. All microarray experiments were performed using Affymetrix Mouse 430A oligonucleotide arrays, as described at http://www.affymetrix.com/support/technical/datasheets/ mouse430_datasheet.pdf (Affymetrix, Santa Clara, CA). RNA was isolated from frozen mouse ear biopsies using the RNeasy mini kit (QIAGEN, Valencia, CA) according to the manufacturer's instructions. The quality and amount of RNA was monitored throughout processing with an Agilent bioanalyzer (Agilent Technologies, Palo Alto, CA) and a NanoDrop ND-1000 UV-Vis spectrophotometer (Nanodrop Technologies, Rockland, DE) . Purified RNA was used to prepare biotinylated target RNA, with minor modifications from the manufacturer's recommendations (http://www.affymetrix.com/support/technical/manual/expression_manual.affx). In brief, 10 g of total RNA was used to generate first-strand cDNA by using a T7-linked oligo(dT) primer. After second-strand synthesis, in vitro transcription was performed with biotinylated nucleotides (Enzo kits; Affymetrix), resulting in approximately 100-fold amplification of cRNA. The target cRNA generated from each sample was processed as per manufacturer's recommendation using an Affymetrix GeneChip instrument system (http://www.affymetrix.com/support/ technical/manual/expression_manual.affx). In brief, spiked controls were added to 15 g of fragmented cRNA before overnight hybridization using 10 g of cRNA. Arrays were then washed and stained with streptavidin-phycoerythrin before being scanned on an Agilent GeneArray scanner. After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3Ј/5Ј ratios for GAPDH were between 0.8 and 1.72, and the ratios for ␤-actin were between 1.07 and 2.71. BioB spike controls were found to be present on 44 of 64 chips that were scanned (75.0%; four were called marginal and not included in the calculation), with BioC, BioD, and CreX also present in increasing intensity. When scaled to a target intensity of 150 (using Affymetrix Microarray Suite 5.0 array analysis software), scaling factors for all arrays were between 0.559 and 2.243.
Microarray Data Analysis. Sample sizes for each treatment group are indicated in the figure legends. Scanned output files from each array were inspected for quality control as described above. Raw signal intensities were normalized using the robust multiarray averaging (RMA) algorithm (Irizarry et al., 2003) . The RMA-normalized data were imported into Partek Pro 6.0 (Partek, St. Charles, MO) and analyzed by principal component analysis (PCA) to determine the significant sources of variability in the data. A correlation coefficient (r) between signal intensities and ear weight was calculated for each gene, and a p value was determined. A set of genes with r Ն 0.90 were used to determine gene pathways and molecular networks highly correlated with ear weight (a measure of drug efficacy). Onto-Express was used to screen for significant pathways modulated by SM exposure (Khatri et al., 2002) .
Quantitative Real-Time PCR. All quantitative real-time PCR (Q-PCR) was performed with Taq-Man PCR reagents and analyzed using the ABI 7500 Sequence Detection system (Applied Biosystems, Foster City, CA). All primers and probes used for Q-PCR analysis were designed using ABI Prism Primer Express version 2.0 (Applied Biosystems) and are listed in Supplemental Table 1 . Primers and probes for each gene were optimized individually for maximum amplification efficiency. A validation experiment was performed to demonstrate that each target gene and endogenous control in a multiplex reaction maintained equal efficiencies (data not shown). Total RNA was purified as described above and DNase I treated on a purification column according to the manufacturer's protocol (QIAGEN). The reverse transcription reaction was carried out using 1 g of total RNA (final concentration 50 ng/l) using SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA). After completion of cDNA synthesis, all reactions were diluted to a final RNA input concentration of 5 ng/l. For each gene analyzed, the experimental samples being tested (three biological replicates for each treatment group) were run in triplicate (three technical replicates) along with the corresponding no-template control and no-amplification control. The primer and probe pair concentrations used for each gene are as follows: GAPDH (endogenous control), 50 nM forward primer, 50 nM reverse primer, 200 nM VIC probe; Fgfr-3, 800 nM forward primer, 800 nM reverse primer, 100 nM Fam probe; Krt1-17, 300 nM forward primer, 50 nM reverse primer, 100 nM Fam probe; and L-myc, 300 nM forward primer, 300 nM reverse primer, 100 nM Fam probe. Amplification reactions were carried out using the instrument default cycle conditions. GAPDH was used as our internal reference gene to calculate the ⌬Ct for each sample assayed. The ⌬⌬Ct was then calculated based on the average ⌬Ct of the naive control samples. The fold change in gene expression was determined as 2
Results
Evaluation of Treatment Compounds in the Mouse
Ear Vesicant Model. Mouse ears were exposed to SM or pretreated with test compounds before SM exposure as described under Materials and Methods. Ear weights measured from 8-mm punch biopsies revealed that SM exposure significantly increases mouse ear weight after 24 h compared with control ear weights (Fig. 1) . Ear weights after pretreatment with indomethacin were decreased compared with SM alone, but they were still significantly greater than the unexposed controls. In contrast, the weights of ears pretreated with OHV or dimercaprol before SM exposure were not significantly different from the control ear weights. Treatment compounds and vehicles alone did not significantly affect ear weight 24 h after exposure.
Gene Expression Profiling of Mouse Ears Pretreated with Candidate Compounds and Exposed to Sulfur
Mustard. Treated and exposed mouse ear biopsies were processed, after obtaining ear weights, for analysis using oligonucleotide microarrays. Data from probed and scanned arrays were normalized using the RMA algorithm and then analyzed by PCA (Fig. 2, A and B) . PCA reduces the complexity of high-dimensional data and simplifies the task of identifying patterns and sources of variability in a large data set. The samples are represented by the points in the threedimensional plot. The distance between any pair of points is related to the similarity between the two observations in high-dimensional space. Samples that are near each other in the plot are similar in a large number of variables (i.e., expression level of individual genes). Conversely, samples that are far apart in the plot are different in a large number of variables. The PCA revealed that the drug-only controls, naive controls, and ethanol vehicle controls partitioned away After 24 h, the weight of an 8-mm ear biopsy was determined for each sample. The SM-exposed group and the SM ϩ indomethacin groups had significantly greater ear weights than all other groups (p Ͻ 0.05, based on a general linear model analysis). Sample sizes were unexposed (naive), n ϭ 5; SM exposed, n ϭ 5; SM ϩ indomethacin, n ϭ 6; SM ϩ OHV, n ϭ 5; SM ϩ dimercaprol, n ϭ 6; indomethacin alone, n ϭ 4; OHV alone, n ϭ 5; dimercaprol alone, n ϭ 4; ethanol alone, n ϭ 3; and methylene chloride alone, n ϭ 21. The error bars represent the mean Ϯ S.D. ‫,ء‬ p Ͻ 0.05.
from the SM-exposed samples and the methylene chloride controls. In addition, SM-exposed samples partitioned away from all the controls. Of the three treatment compounds evaluated, the mouse ears pretreated with indomethacin before SM exposure partitioned closest to the SM-exposed samples. In contrast, the mouse ears pretreated with OHV or dimercaprol before SM exposure partitioned closer to the methylene chloride control samples. This partitioning of the pretreated samples was also observed when looking at ear weights. The SM-exposed ears weighed more 24 h after ex- 
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at ASPET Journals on November 13, 2017 jpet.aspetjournals.org posure compared with controls ( Fig. 1 ). Ears pretreated with indomethacin also showed a statistically significant increase in ear weight compared with control ear weights ( Fig. 1) and partitioned closer to the SM-exposed ears. In contrast, OHVand dimercaprol-pretreated ear weights are not significantly different 24 h after SM exposure compared with control ear weights ( Fig. 1) , and they partition closer to methylene chloride controls. When visualized using ellipsoids representing a Euclidean space Ϯ2 S.D. from the mean of each group, considerable overlap between the SM-exposed samples and the indomethacin-pretreated samples was observed (Fig. 2B) .
The OHV-and dimercaprol-pretreated samples do not overlap with the SM-exposed samples to the same extent, but they do overlap with the methylene chloride-exposed control group (Fig. 2B) . Tables 1 and 2 , respectively. To determine the molecular functions and biological processes that are highly correlated with ear weight, the genes with r Ն 0.90 were mapped to the Gene Ontology (The Gene Ontology Consortium, 2000) using the Web-based search engine OntoExpress (Khatri et al., 2002) . Onto-Express translates lists of differentially regulated genes identified in high-throughput gene expression experiments into functional profiles based on the gene ontology, and a statistical significance value is calculated. Table 3 summarizes genes that represent the molecular functions most highly correlated with ear weight, and Table 4 summarizes the genes that represent the biological processes most highly correlated with ear weight. An examination of the biological processes most highly correlated with ear weight (based on genes with an r Ն 0.90) reveals several major categories of biological processes: cell cycle regulation, inflammation, signal transduction, and cytoskeletal and cell adhesion processes. The gene expression profiles of genes that are classified in each of these biological processes are shown in Figs. 3 (cell cycle regulation), 4 (in- All genes with an r Ն 0.90 (see Tables 1 and 2) were uploaded into OntoExpress. Gene ontology categories containing less that two genes were excluded from this Fig. 3 . Gene expression profiles of individual cell cycle control and cellular growth genes that are highly correlated with SM-induced ear weight gain. Genes with expression patterns that were highly correlated (r Ն 0.9) with ear weight were identified by gene expression profiling. Gene ontology-based analysis was used to determine significantly altered biological processes. Individual genes were graphed according to treatment group and gene expression signal intensity. Error bars represent mean Ϯ S.D. The data were analyzed for statistical significance using a oneway ANOVA with a Dunnett's post test to look for treatment groups significantly different from the unexposed control group. ‫,ء‬ p Ͻ 0.05; ‫,ءءء‬ p Ͻ 0.001.
Identification of Genes Whose Expression Profile
Correlates with Ear Weight. The gene expression profiles were analyzed and a correlation coefficient between signal intensity (representing gene expression level) and ear weight was determined for each gene. Genes showing a positive correlation or a negative correlation with ear weight to an r Ն 0.90 are reported in
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at ASPET Journals on November 13, 2017 jpet.aspetjournals.org Fig. 5 . Gene expression profiles of individual signal transduction genes that are highly correlated with SM-induced ear weight gain. Genes with expression patterns that were highly correlated (r Ն 0.9) with ear weight were identified by gene expression profiling. Gene ontology-based analysis was used to determine significantly altered biological processes. Individual genes were graphed according to treatment group and gene expression signal intensity. Error bars represent mean Ϯ S.D. The data were analyzed for statistical significance using a one-way ANOVA with a Dunnett's post test to look for treatment groups significantly different from the unexposed control group. ‫,ء‬ p Ͻ 0.05; ‫,ءءء‬ p Ͻ 0.001. 
Validation of Selected Microarray Results by Q-PCR.
The reliability of our microarray data was confirmed using Q-PCR analysis of several genes whose expression levels were highly correlated with ear weight. As shown in Supplemental Fig. 1 , the relative expression levels of Fgfr3 , and L-myc based on Q-PCR analysis were consistent with the expression profiles determined by microarray analysis.
Discussion
To gain insight into the molecular mechanism of SM toxicity, we used oligonucleotide microarrays to determine the gene expression profile of mouse ear skin exposed to SM. These results were compared with gene expression profiles determined from ears that were pretreated with one of three treatment compounds (dimercaprol, OHV, or indomethacin) . Principal component analysis revealed that the gene expression profiles of dimercaprol-and OHVpretreated tissues were similar to profiles from tissues exposed to vehicle alone (methylene chloride). In contrast, the gene expression profile of indomethacin-pretreated tissues was similar to that of tissues exposed only to SM. These profiles complement the ear weight data, which show that indomethacin is the least effective treatment compound for attenuating postexposure increases in mouse ear weight. Statistical analysis of the gene expression profiles revealed specific sets of genes that were highly correlated with SM-induced changes in ear weight (r Ն 0.90). Gene ontology mapping of these gene sets revealed several major biological processes that were affected concomitantly with increased ear weight. These were cell cycle regulation, inflammation, signal transduction, and cytoskeletal and cell adhesion processes.
Previous work has examined changes in gene expression after exposure to SM. The systems studied include mouse ear (Sabourin et al., 2000 (Sabourin et al., , 2004a Rogers et al., 2004) , pig skin (Sabourin et al., 2002) , cultured human keratinocytes Fig. 6 . Gene expression profiles of individual cytoskeletal and cell adhesion genes that are highly correlated with SM-induced ear weight gain. Genes with expression patterns that were highly correlated (r Ն 0.9) with ear weight were identified by gene expression profiling. Gene ontology-based analysis was used to determine significantly altered biological processes. Individual genes were graphed according to treatment group and gene expression signal intensity. Error bars represent mean Ϯ S.D. The data were analyzed for statistical significance using a one-way ANOVA with a Dunnett's post test to look for treatment groups significantly different from the unexposed control group. ‫,ء‬ p Ͻ 0.05; ‫,ءءء‬ p Ͻ 0.001.
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at ASPET Journals on November 13, 2017 jpet.aspetjournals.org Platteborze, 2003) , HepG2 cells transfected with various stress gene reporter constructs (Schlager and Hart, 2000) , and Jurkat cells exposed to the mustardrelated compound chloroethyl ethyl sulfide (CEES) (Zhang et al., 2002) . Our previous studies show that vanilloids reduce skin edema and cytokine mRNA expression after SM exposure in a mouse model (Sabourin et al., 2003 (Sabourin et al., , 2004b . This is the first study to characterize SM-induced changes in gene expression in relation to a characterized endpoint of SM exposure (ear weight) and also to examine the effect of treatment compounds on SM-induced gene expression using a global gene expression approach. These results provide important details that were previously lacking, and indicate that gene expression profiles may help to uncover the mechanisms of an observed phenotypic response (e.g., increased ear weight). Interestingly, few of the genes found to be highly correlated with increased ear weight showed what would normally be considered significant changes in gene expression (Ͼ2-fold change). Our results suggest that many of the genes highly correlated with a clinical endpoint may not show large -fold changes in gene expression. Further investigation with a broader time course and dose response may reveal more dynamic changes in the expression levels of these genes.
Cell cycle regulation has been previously implicated as a biological process affected by SM exposure. This has been attributed to the ability of SM to cross-link DNA by alkylation at the N-7 of guanine (Papirmeister et al., 1991) . The cell cycle has been shown to stop at the G 1 /S transition after SM exposure (Smith et al., 1993) . p53 is an important component of the G 1 /S cell cycle checkpoint. Rosenthal et al. (1998) showed that p53 accumulates after SM exposure in cultured human keratinocytes. Schlager and Hart (2000) showed increases in activity of the p53 promoter response element in HepG2 cells transfected with reporter constructs. We recently showed that rat pulmonary tissue exposed to SM via an intravenous route elicits a robust p53 response . We also reported that p53 is phosphorylated on serine 15 within 15 min of SM exposure in cultured human keratinocytes (Minsavage and Dillman, 2005) . Interestingly, it has been shown that there is a high incidence of lung cancer in former mustard gas workers, and there are p53 mutations in many of these cancers (Manning et al., 1981; Tokuoka et al., 1986; Easton et al., 1988; Nishimoto et al., 1988; Takeshima et al., 1994) . The relationship between p53 activation, the cell cycle, and the genes identified in SMexposed mouse skin and rat lung remains to be determined.
Up-regulation of cytokines and chemokines after SM exposure has been well characterized in a number of recent studies (Arroyo et al., 1999; Lardot et al., 1999; Sabourin et al., 2000 Sabourin et al., , 2002 Sabourin et al., , 2003 Sabourin et al., , 2004a . Related to this, a number of cell signaling pathways have been identified that are activated or altered after SM exposure. Pharmacological inhibition of the p38 mitogen-activated protein kinase (MAPK14) has been reported to block up-regulation of cytokine production in response to SM exposure in cultured keratinocytes (Dillman et al., 2004) . In addition the transcription factor nuclear factor-B, which is involved in both inflammation and apoptosis, is activated after SM exposure in cultured cells (Atkins et al., 2000; Schlager and Hart, 2000) . In other systems, nuclear factor-B has been shown to be activated by CEES in guinea pig lung (Chatterjee et al., 2003) , and the Akt pathway is perturbed by CEES exposure in Jurkat cells (Zhang et al., 2002) . It is not clear how CEES exposure relates to SM exposure, but it is clear that signaling pathways associated with inflammatory response are activated by SM exposure. These signaling pathways may be potential therapeutic targets for attenuating cytokine production and the subsequent recruitment of activated immune cells to the site of injury.
The cytoskeleton is an important target of SM exposure. Several studies have identified keratin proteins as direct targets of SM alkylation (van der Schans et al., 2002; Dillman et al., 2003) . In addition, cross-linking of keratin filaments by SM, but not by other alkylating agents (e.g., CEES), has been observed (Dillman et al., 2003) . This alkylation results in collapse of the keratin intermediate filament network and subsequent adverse changes in cellular morphology Madren-Whalley, 2000, 2003) . Furthermore, exposure to SM results in changes in the keratin proteins that are expressed in cultured human keratinocytes (Rosenthal et al., 1998) . Western blotting of keratinocytes exposed to SM revealed that keratin-5 (K5) and keratin-14 (K14) protein levels decrease, and keratin-1 (K1) and keratin-10 (K10) protein levels increase. K5/K14 are associated with proliferating cells in the basal layer of the epidermis, whereas K1/K10 are associated with terminally differentiating cells in the suprabasal layers of the epidermis. SM exposure also results in perturbation of the actin cytoskeleton (Werrlein et al., 2005) . Our data regarding altered gene expression are in agreement with these observations that cytoskeletal proteins are adversely affected by SM exposure. Although direct effects of SM on the microtubule network have not been reported to date, we observe changes in the mRNA levels of microtubule-based motor proteins from the kinesin family (Fig. 6) , suggesting that changes in microtubule-based motility may result from SM exposure.
In conclusion, our results demonstrate that gene expression profiling can provide additional insight into the pathways important in SM-induced injury and which pathways may be potential targets for future development of antivesicant therapeutics. Our results suggest that gene expression profiling can be predictive of drug efficacy and imply that this could be an important tool in predictive toxicology and drug development. These approaches are of particular importance in the discovery and testing of pharmacological treatments for toxicant exposure, since in these cases traditional clinical trials for regulatory approval are not an option.
